Astrid Zedlitz Johansen (Astrid Z Johansen)

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 5

Top Topics

Lymph Node Metastasis

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Liva K Stuhr, Kasper Madsen, Astrid Zedlitz Johansen, Inna Markovna Chen, Carsten Palnaes Hansen, Lars Henrik Jensen, Torben Frøstrup Hansen, Kirstine Kløve-Mogensen, Kaspar R Nielsen, Julia Sidenius Johansen
Combining sCD163 with CA 19-9 Increases the Predictiveness of Pancreatic Ductal Adenocarcinoma. Cancers 15 (3) (2023)
Liva K Stuhr, Kasper Madsen, Astrid Zedlitz Johansen, Inna Markovna Chen, Carsten Palnaes Hansen, Lars Henrik Jensen, Torben Frøstrup Hansen, Kirstine Kløve-Mogensen, Kaspar R Nielsen, Julia Sidenius Johansen
Combining sCD163 with CA 19-9 Increases the Predictiveness of Pancreatic Ductal Adenocarcinoma. Cancers 15 (3) (2023)
Simone Kloch Bendtsen, Maria Perez-Penco, Mie Linder Hübbe, Evelina Martinenaite, Morten Orebo Holmström, Stine Emilie Weis-Banke, Nicolai Grønne Jørgensen, Mia Aaboe Jørgensen, Shamaila Munir Ahmad, Kasper Mølgaard Jensen, Christina Friese, Mia Thorup Lundsager, Astrid Zedlitz Johansen, Marco Carretta, Niels Odum, Özcan Met, Inge Marie Svane, Daniel Hargbøl Madsen, Mads Hald Andersen
Peptide vaccination activating Galectin-3-specific T cells offers a novel means to target Galectin-3-expressing cells in the tumor microenvironment. Oncoimmunology 11 (1) (2022)
Sidsel C Lindgaard, Emil Maag, Zsófia Sztupinszki, Inna Markovna Chen, Astrid Zedlitz Johansen, Benny V Jensen, Stig E Bojesen, Dorte L Nielsen, Zoltan Szallasi, Julia S Johansen
Circulating Protein Biomarkers for Prognostic Use in Patients with Advanced Pancreatic Ductal Adenocarcinoma Undergoing Chemotherapy. Cancers 14 (13) (2022)
Astrid Zedlitz Johansen, Marco Carretta, Marie-Louise Thorseth, Shawez Khan, Klaire Yixin Fjæstad, Christian Beltoft Bröchner, Hannes Linder, Christina Ankjærgaard, Marco Donia, Inna Markovna Chen, Dorte Lisbet Nielsen, Claus Preibisch Behrens, Daniel Hargbøl Madsen
Chitooligosaccharides Improve the Efficacy of Checkpoint Inhibitors in a Mouse Model of Lung Cancer. Pharmaceutics 14 (5) (2022)